21:15 , May 18, 2018 |  BioCentury  |  Finance

China comes to Europe

  The historically underfunded European biotech sector is in the early stages of tapping into a new stream of capital thanks to the explosion of biomedical innovation in China, which has spawned a wave of...
07:00 , Sep 27, 2010 |  BC Week In Review  |  Financial News

immatics completes venture financing

immatics biotechnologies GmbH , Tuebingen, Germany   Business: Cancer, Supply/Service   Date completed: 9/21/10   Type: Venture financing   Raised: €53.8 million ($70.5 million)   Investors: dievini Hopp BioTech; MIG Funds; AT Impf GmbH; Wellington...